1 study found for:    24825642 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed LDL-C Assessment w/ PCSK9 Monoclonal Antibody Inhibition Combined With Statin Therapy-2
Condition: Hyperlipidemia
Interventions: Biological: evolocumab (AMG 145);   Other: Ezetimibe;   Other: Placebo (administered subcutaneously);   Other: Placebo (administered orally);   Drug: Atorvastatin;   Drug: Rosuvastatin;   Drug: Simvastatin

Indicates status has not been verified in more than two years